

The Daily
The New York Times
This is what the news should sound like. The biggest stories of our time, told by the best journalists in the world. Hosted by Michael Barbaro, Rachel Abrams and Natalie Kitroeff. Twenty minutes a day, six days a week, ready by 6 a.m.
Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher.
Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher.
Episodes
Mentioned books

44 snips
Mar 3, 2023 • 30min
Why Russia Is Taking Thousands of Ukrainian Children
Emma Bubola, a New York Times reporter based in London, discusses the harrowing relocation of Ukrainian children during the conflict. She reveals how many children were swept up by Russian forces and placed in families, often under the guise of humanitarian efforts. Bubola shares the poignant story of Anya, a young girl separated from her mother and caught in a cycle of propaganda. The conversation highlights the chilling exploitation of these children as tools of state narratives while exploring the devastating impact of war on families.

33 snips
Mar 2, 2023 • 25min
Will the Supreme Court Let Biden Cancel Student Debt?
President Biden's bold plan to cancel $400 billion in student debt faces scrutiny from the Supreme Court. Legal experts debate whether he has the authority under the HEROES Act, with justices expressing skepticism over its fairness. Protests from those burdened by loans highlight public support, while concerns about taxpayer implications loom large. The podcast also touches on parallel protests in Israel, showcasing global unrest over government actions. Tune in for a deep dive into the legal and political ramifications of this pivotal case.

27 snips
Mar 1, 2023 • 31min
A Threat to Abortion Pills. Plus, the U.S. Shares Secrets
Pam Belluck, a health and science correspondent for The New York Times, discusses the looming legal battle over the abortion pill mifepristone, highlighting its significance for reproductive rights. Julian E. Barnes, a national security correspondent, sheds light on the Biden administration's unprecedented disclosure of intelligence regarding China's potential military support for Russia. Their conversation probes the implications of these issues on both domestic health policies and international diplomacy.

48 snips
Feb 28, 2023 • 21min
Why So Many Buildings Collapsed in Turkey
Ben Hubbard, Istanbul bureau chief for The New York Times, offers expert insights on the catastrophic earthquake in Turkey. He discusses the troubling practices in Turkey’s construction sector, revealing conflicts of interest where builders self-inspect. The conversation digs into government negligence, including repeated waivers of building code violations. With public outrage growing, Hubbard highlights the accountability measures against builders and architects, emphasizing the devastating impact of inadequate safety standards on the tragic loss of life.

38 snips
Feb 27, 2023 • 23min
Why Election Denialism Might Cost Fox News $1.6 Billion
In this engaging conversation, Jeremy W. Peters, a New York Times correspondent specializing in media and politics, dives into the legal battle facing Fox News over its election fraud claims. He highlights how internal communications reveal a knotted relationship between truth and profit, with the network prioritizing ratings over journalistic integrity. The discussion also explores the complexities of proving defamation and the broader implications for media accountability in today's polarized environment, raising questions about the responsibility of news organizations.

95 snips
Feb 26, 2023 • 48min
The Sunday Read: ‘Elon Musk’s Appetite for Destruction’
The podcast dives into the complex world of Tesla's Autopilot amid looming lawsuits after crashes. It examines Elon Musk's bold vision for self-driving cars and the ethical dilemmas that arise from rapid technological advancements. Listeners hear personal accounts from users torn between brand loyalty and safety concerns. The discussion addresses the fine line between innovation and risk, highlighting real-world implications and societal responsibilities as Tesla navigates its controversial path forward.

21 snips
Feb 24, 2023 • 34min
A Year of War in Ukraine
Irina Tsibuk, a paramedic on the front lines near Bakhmut, shares harrowing tales of survival and the emotional toll that war inflicts on those who serve. Olga Brzeul, a film curator, recalls the bittersweet memories of her husband Victor, who died in the conflict, capturing the complex dance of love and loss amidst chaos. They discuss the agonizing shifts in the war's landscape, the cost of resilience, and how the realities of combat have forever changed their lives.

60 snips
Feb 23, 2023 • 28min
A Ruling That Could End the Internet as We Know It
Adam Liptak, Supreme Court correspondent for The New York Times, dives into the pressing legal battle of Gonzalez v. Google, focusing on the potential overhaul of Section 230, which currently shields tech companies from liability for user content. He explains how a family's lawsuit following a tragic attack could reshape accountability for online platforms. The discussion spotlights the implications of algorithm-driven content recommendations and the delicate balance between innovation and responsibility in the digital landscape.

18 snips
Feb 22, 2023 • 28min
The Veterans Fighting to Legalize Psychedelics
Andrew Jacobs, a health and science reporter for The New York Times, and Juliana Mercer, a veteran advocate, tackle the urgent issue of psychedelic legalization for therapeutic use. Mercer shares her personal struggle with PTSD and how psychedelics offer a promising path to healing. They discuss the evolving perspectives on these substances and the growing bipartisan support fueled by veteran advocacy. The conversation highlights Oregon's pioneering steps toward legal psilocybin and the FDA's recognition of MDMA for PTSD treatment, marking a significant shift in drug policy.

64 snips
Feb 21, 2023 • 29min
Why ‘Made in China’ Is Becoming ‘Made in Mexico’
Peter S. Goodman, Global economics correspondent for The New York Times, explores the significant manufacturing shift from China to Mexico. He discusses how the pandemic-induced supply chain disruptions prompted Chinese companies to set up factories in Mexico, with Laredo emerging as a vital trade hub. Goodman highlights the benefits for Mexican workers and American consumers, including job creation and better wages. He also examines the cultural and labor challenges that Chinese firms face in Mexico, reflecting on broader trends in global manufacturing.


